Back to Search
Start Over
Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions
- Source :
- European Journal of Haematology. 87:244-252
- Publication Year :
- 2011
- Publisher :
- Wiley, 2011.
-
Abstract
- Objective: Anaemia in low-risk myelodysplastic syndromes (MDS) is associated with reduced quality of life (QoL). Response to treatment with erythropoietin +/- granulocyte colony-stimulating factor ...
- Subjects :
- medicine.medical_specialty
Hematology
Darbepoetin alfa
business.industry
Myelodysplastic syndromes
General Medicine
Filgrastim
medicine.disease
Gastroenterology
Surgery
Granulocyte colony-stimulating factor
Clinical trial
Quality of life
Erythropoietin
hemic and lymphatic diseases
Internal medicine
medicine
business
medicine.drug
Subjects
Details
- ISSN :
- 09024441
- Volume :
- 87
- Database :
- OpenAIRE
- Journal :
- European Journal of Haematology
- Accession number :
- edsair.doi...........b491c67009056b7fdfb5c9d7d7e66630